Cohance Lifesciences Limited vs Acutaas Chemicals Limited

MoneyDock presents a comparative analysis between Cohance Lifesciences Limited (COHANCE.NS) and Acutaas Chemicals Limited (ACUTAAS.NS). While specific operational details for both companies are not provided in the given data, they are both publicly traded entities on the Indian stock exchange, making them relevant for investors looking to diversify within the market. This comparison will leverage key financial metrics such as current price, 52-week highs and lows, and 1-year returns to shed light on their recent performance and potential appeal to different investor profiles. Given the absence of Trailing P/E and Market Cap data for both, our analysis will focus primarily on price action and percentage returns.

Key Financial Metrics Comparison

Analysis: Valuation, Returns, and Stability

Valuation: With Trailing P/E and Market Cap data unavailable, a direct valuation comparison is challenging. However, we can observe their current price relative to their 52-week ranges. Cohance Lifesciences is currently trading at ₹463.55, which is closer to its 52-week high of ₹539.85 than its 52-week low of ₹279.90. This suggests it has recovered from its lows but is still below its recent peak. Acutaas Chemicals, on the other hand, is at ₹3348.80, also closer to its 52-week high of ₹3694.80 compared to its 52-week low of ₹1602.50. Without fundamental valuation metrics like P/E, it's hard to definitively say which is 'cheaper' based solely on price. Both appear to be trading nearer their upper annual bounds.

Returns: This is where Acutaas Chemicals Limited clearly stands out. It has delivered a phenomenal 1-year return of 105.27%, more than doubling investors' money over the past year. In stark contrast, Cohance Lifesciences Limited has seen a negative 1-year return of -12.48%, indicating a period of underperformance and capital erosion for its shareholders. For investors prioritizing recent performance, Acutaas Chemicals is the clear winner.

Stability: The 52-week range can offer insights into price volatility. Cohance Lifesciences has a range from ₹279.90 to ₹539.85, indicating a potential fluctuation of over 90% from its low to high. Acutaas Chemicals has a range from ₹1602.50 to ₹3694.80, representing a swing of over 130%. While both show significant volatility, Acutaas Chemicals' higher percentage swing over the past year, coupled with its substantial positive return, suggests it's been a more dynamically moving stock. The negative return for Cohance, despite being off its lows, points to a less stable performance in a positive direction over the last year. Acutaas's strong returns might appeal to those comfortable with higher volatility, while Cohance's recent negative trend might concern those seeking stability.